BCIQ Profiles

Company Profile Report
DIST_0422_j.cell.2021.03.048

Small molecule activator of chaperone-mediated autophagy for Alzheimer’s

Jun 5, 2021 | 12:04 AM GMT

DISEASE CATEGORY: Neurology

INDICATION: Alzheimer’s disease

A phenylacetamide-based compound that activates chaperone-mediated

Read the full 236 word article

How to gain access

Continue reading with a
two-week free trial.